Stocks to buy

Human life expectancy has doubled since the 1900s, mostly attributed to advancements in lifestyle, living standards and medicine. Thanks to biotech companies that produce transformative drugs and treatments, we now have the collective ability to combat diseases that used to bring entire nations down. And it’s getting better all the time. So, it’s no surprise
0 Comments
Institutional investors represent the so-called big money that wields significant influence over the stock market. That influence manifests in many ways.  A negative view of institutional investors is that they only care about themselves, not smaller retail investors, and they simply have too much control overall. A more positive take is that institutional investors, with
0 Comments
Predicting the future market leaders is essential, given how quickly the technology and finance sectors are developing. Three companies will lead in 2025. By utilizing solid growth strategies, strong financial performance, and creative solutions, these companies are achieving major advancements in application software, consumer finance, and systems software. The first one stands out for its
0 Comments
Enterprise AI stocks tend to represent companies that focus on solving complex business problems by leveraging powerful algorithms. Consumer AI, on the other hand, tends to be less complex and deals primarily with user interface and experience overall. Stocks representing companies in both realms represent incredible opportunities. However, this article will focus on stocks representing
0 Comments
Despite beating earnings per share estimates for three consecutive quarters Advanced Micro Devices (NASDAQ:AMD) stock fell nearly 9% to $144.27 leading to a 14% decline in three months, contrasting Nvidia’s 22% rise. The reasons for this slump include ASML Holding’s missed orders forecast and Nvidia’s perceived role as an inflation hedge. AMD expects to sell
0 Comments
In a recent deep-dive research report on the state of the MedTech (medical technology) sector, Oppenheimer highlighted the potential of artificial intelligence (AI) in the sector, noting its capacity to save an estimated $200 billion to $300 billion annually through enhanced workflow management. Inspired by these findings, this article explores the three best MedTech stocks
0 Comments